Serum uric acid levels and inflammatory markers with respect to dipping status: A retrospective analysis of hypertensive patients with or without chronic kidney disease

References

• Pereira BJ. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 2000;57:351–65.
   PubMed Web of Science ®Google Scholar
• Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001;12:1713–20.
   PubMed Web of Science ®Google Scholar
• An HR, Park S, Yoo TH, et al. Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease. J Korean Med Sci 2011;26:1185–90.
   PubMed Web of Science ®Google Scholar
• Timio M, Venanzi S, Lolli S, et al. “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995;43:382–87.
   PubMed Web of Science ®Google Scholar
• Liu M, Takahashi H, Morita Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003;18:563–69.
   PubMed Web of Science ®Google Scholar
• Peixoto AJ, White WB. Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int 2007;71:855–60.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 2009;14:2–11.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Light RP. GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant 2009;24:2400–406.
   PubMed Web of Science ®Google Scholar
• Torbjornsdotter TB, Jaremko GA, Berg UB. Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with type I diabetes. Diabetologia 2001;44:865–73.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Kariyanna SS, Light RP. Circadian blood pressure classification scheme and the health of patients with chronic kidney disease. Am J Nephrol 2009;30:536–46.
   PubMed Web of Science ®Google Scholar
• Kaya MG, Yarlioglues M, Gunebakmaz O, et al. Platelet activation and inflammatory response in patients with nondipper hypertension. Atherosclerosis 2010;209:278–82.
   PubMed Web of Science ®Google Scholar
• Tosu AR, Demir S, Selcuk M, et al. Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readings. Postepy Kardiol Interwencyjnej 2014;10:98–103.
   PubMed Web of Science ®Google Scholar
• Liese AD, Hense HW, Lowel H, et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999;10:391–97.
   Google Scholar
• Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000;18:1149–54.
   PubMed Web of Science ®Google Scholar
• Feig DI, Nakagawa T, Karumanchi SA, et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004;66:281–87.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007;39:1227–33.
   PubMed Web of Science ®Google Scholar
• Erdogan D, Icli A, Aksoy F, et al. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure. Chronobiol Int 2013;30:973–80.
   PubMed Web of Science ®Google Scholar
• Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351–57.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Zoppini G, et al. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 2005;22:999–1004.
   PubMed Web of Science ®Google Scholar
• Pfützner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 2006;8:28–36.
   PubMed Web of Science ®Google Scholar
• Reddan DN, Klassen PS, Szczech LA, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant 2003;18:1167–73.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Ozcicek F, Ozcicek A, Akbas EM, Erdur FM, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients. Hemodial Int 2014;18:47–53.
   PubMed Web of Science ®Google Scholar
• Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499–503.
   PubMed Web of Science ®Google Scholar
• Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: A community-based study. Circ Cardiovasc Qual Outcomes 2009;2:656–62.
   PubMed Web of Science ®Google Scholar
• Rudiger A, Burckhardt OA, Harpes P, Muller SA, Follath F. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med 2006;24:451–54.
   PubMed Web of Science ®Google Scholar
• Akkaya E, Gul M, Ugur M. Platelet to lymphocyte ratio: A simple and valuable prognostic marker for acute coronary syndrome. Int J Cardiol 2014;177:597–98.
   PubMed Web of Science ®Google Scholar
• Balta S, Demırkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int 2013;17:668–69.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005;68:237–45.
   PubMed Web of Science ®Google Scholar
• Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2009;53:596–605.
   PubMed Web of Science ®Google Scholar
• Rees AJ. The role of infiltrating leukocytes in progressive renal disease: implications for therapy. Natl Clin Pract Nephrol 2006;2:348–49.
   PubMedGoogle Scholar
• Siebers R, Maling T. Mean platelet volume in human essential hypertension. J Hum Hypertens 1995;9:207.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415–22.
   PubMed Web of Science ®Google Scholar
• Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653–57.
   PubMed Web of Science ®Google Scholar
• Nunez J, Nunez E, Bodi V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008;101:747–52.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail 2012;34:155–59.
   PubMed Web of Science ®Google Scholar
• Açar G, Kalkan ME, Avci A, et al. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost 2015;21:462–68.
   PubMed Web of Science ®Google Scholar
• Gary T, Pichler M, Belaj K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013;8:e67688.
   PubMed Web of Science ®Google Scholar
• Ugur M, Gul M, Bozbay M, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis 2014;25:806–11.
   PubMed Web of Science ®Google Scholar
• Kwon HC, Kim SH, Oh SY, et al. Clinical significance of preoperative neutrophil lymphocyte versus platelet lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012;17:216–22.
   PubMed Web of Science ®Google Scholar
• Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J. Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem 2013;46:1353–71. Review.
   PubMed Web of Science ®Google Scholar
• Erturk M, Cakmak HA, Surgit O, et al. The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol 2014;64:371–76.
   PubMed Web of Science ®Google Scholar
• Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014;36:217–21.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Murat SN, Yarlioglues M. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol 2014;114:972–78.
   PubMed Web of Science ®Google Scholar
• Tanındı A, Erkan AF, Ekici B, Alhan A, Tore HF. Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion. Turk Kardiyol Dern Ars 2014;42:125–30.
   PubMedGoogle Scholar
• Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 1997;12:2301–07.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006;69:1175–80.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Nakagawa K, Kimura M, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertensiona comparison of dippers and non-dippers. J Am Coll Cardiol 2002;40:2039–43.
   PubMed Web of Science ®Google Scholar
• Inanc T, Kaya MG, Yarlioglues M, et al. The mean platelet volume in patients with non-dipper hypertension compared to dipper hypertension and normotensives. Blood Press 2010;19:81–5.
   PubMed Web of Science ®Google Scholar
• Ordu S, Ozhan H, Caglar O, et al. Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Press 2010;19:26–30.
   PubMed Web of Science ®Google Scholar
• Surgit O, Erturk M, Akgul O, et al. Assessment of mean platelet volume and soluble CD40 ligand levels in patients with non-dipper hypertension, dippers and normotensives. Clin Exp Hypertens 2015;37:70–4.
   PubMed Web of Science ®Google Scholar
• Spencer GG, Gurney D, Blann AD, et al. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension 2002;40:61–6. ASGOT Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial.
   Google Scholar
• Gomi T, Ikeda T, Shibuya Y, Naqao R. Effects of anti-hyper-tensive treatment on platelet function in essential hypertension. Hypertens Res 2000;23:567–72.
   PubMed Web of Science ®Google Scholar
• Pusuroglu H, Cakmak HA, Erturk M, et al. Assessment of the relation between mean platelet volume, non-dipping blood pressure pattern, and left ventricular mass index in sustained hypertension. Med Sci Monit 2014;20:2020–26.
   PubMed Web of Science ®Google Scholar
• Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol 2016;85:199–208.
   Web of Science ®Google Scholar
• Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 2005;46:514–20.
   PubMed Web of Science ®Google Scholar
• Palmer BF. Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol 2007;27:287–93.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Kariyanna SS, Light RP. Prognostic value of circadian blood pressure variation in chronic kidney disease. Am J Nephrol 2009;30:547–53.
   PubMed Web of Science ®Google Scholar
• Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 2013;37:2688–92.
   PubMed Web of Science ®Google Scholar
• Geng Y, Qi Q, Sun M, Chen H, Wang P, Chen Z. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur J Surg Oncol 2015;41:1508–14.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Costantini F, Bucci A, et al. Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. Am J Hypertens 1999;12:356–63.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997;10:1201–07.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens Suppl 1991;9:S42–44.
   PubMedGoogle Scholar
• Scuteri A, Cacciafesta M, dePropris AM, et al. Platelet size and left ventricular hypertrophy in hypertensive patients over 50 years of age. Eur J Clin Invest 1995;25:874–76.
   PubMed Web of Science ®Google Scholar
• Bulur S, Onder H, Aslantas Y, et al. Relation between indices of end-organ damage and mean platelet volume in hypertensive patients. Blood Coagul Fibrinolysis 2012;23:367–69.
   PubMed Web of Science ®Google Scholar